International Atomic Energy Agency   Report issue

Government Phase 3
Founded: Vienna Austria (1957)

Organization Overview

First Clinical Trial
2004
NCT00122746
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

International Atomic Energy Agency | International Atomic Energy Agency (IAEA)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 3)

Carcinoma, Hepatocellular (Phase 3)

Carcinoma, Squamous Cell (Phase 3)

Malaria (Phase 3)

Malnutrition (Phase 3)

Parasitemia (Phase 3)

Squamous Cell Carcinoma of Head and Neck (Phase 3)

Uterine Cervical Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 14
  • # of Trial APIs: 13